Corvara Bioscience does not sell BPC-157. This overview is provided for educational reference only.

BPC-157: A Research Overview

BPC-157 is a synthetic peptide that has attracted significant interest in preclinical research, particularly in models of tissue repair. This overview summarizes what BPC-157 is, the pathways researchers study, and the important context that its evidence base comes almost entirely from animal and laboratory models.

A synthetic 15-mer peptide

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence identified in gastric juice.

Preclinical evidence base

Its research literature is concentrated in animal and in-vitro models, especially of tissue healing.

Angiogenesis-focused mechanisms

Proposed mechanisms center on new blood vessel formation and growth-factor signaling.

Not an approved drug

Human clinical evidence is very limited; it is handled strictly as research material.

What is BPC-157?

BPC-157, sometimes written as "Body Protection Compound-157," is a synthetic peptide made of 15 amino acids. Its sequence is derived from a portion of a protein originally identified in gastric (stomach) juice. Much of the early research interest focused on gastrointestinal models before broadening to other tissue types. It is worth stating clearly: BPC-157 is an investigational research peptide. It has not been approved as a medicine, and the bulk of its literature comes from studies in rodents and cell cultures rather than large human trials.

Mechanisms studied in the literature

• Angiogenesis: promotion of new blood vessel formation, which supports tissue repair by improving blood supply to a healing area.

• Growth-factor and receptor signaling: interactions with pathways such as VEGFR2 that are involved in vascular and tissue growth.

• Nitric oxide pathway modulation: influence on the NO system, which plays a role in blood flow and vascular tone.

• Interaction with growth-factor systems implicated in connective tissue repair.

These are proposed mechanisms drawn from experimental models; researchers continue to investigate how they translate, if at all, beyond those models.

Areas of preclinical research interest

  • Tendon, ligament & muscle repair

    Studied in rodent injury models.

  • Gastrointestinal tissue integrity

    Studied in rodent and in-vitro models.

  • Wound & soft-tissue healing

    Studied in preclinical models.

  • Vascular & angiogenic signaling

    Studied in cell culture and animal studies.

Understanding the evidence base

A responsible summary has to be honest about the strength of the evidence. BPC-157 has generated a substantial body of promising preclinical results, which is why it remains a popular subject of study. At the same time, well-controlled human clinical trials are scarce. Findings in rodents do not automatically carry over to other species, and enthusiasm in secondary sources sometimes outpaces what the primary literature demonstrates. Researchers should read the original studies critically and note the model system, dose, and endpoints used.

Handling and quality considerations

Like other research peptides, BPC-157 is supplied as a lyophilized powder and requires proper reconstitution and storage to remain stable. Because purity directly affects reproducibility, a documented certificate of analysis confirming identity and purity is especially important for a peptide as widely studied, and widely counterfeited, as this one.

Purity you can document

Because BPC-157 is widely copied, a certificate of analysis confirming identity and purity is essential to reproducible research.

Continue Learning

  • What Are Research Peptides? →

    Start with the fundamentals.

    Learn more

  • Understanding GLP-1 Receptor Agonists →

    How semaglutide, tirzepatide, and retatrutide differ.

    Learn more

  • Peptide Purity & Certificates of Analysis →

    How to read a COA and why purity matters.

    Learn more

  • Peptide Reconstitution & Handling Guide →

    Solvents, method, and storage for stability.

    Learn more

Frequently asked questions

BPC stands for "Body Protection Compound." It is a synthetic 15-amino-acid sequence derived from a protein region originally identified in gastric juice.

It is widely studied and widely copied, so quality varies between sources. Impurities or incorrect sequences undermine reproducibility, so a COA verifying identity and purity matters.

No. It is an investigational research peptide, not an approved drug. Its evidence comes primarily from preclinical animal and laboratory studies rather than large human trials.

Preclinical research is done in cell cultures and animal models before any human trials. Most BPC-157 findings come from this stage, which is why results don't automatically translate to other species.

Research use only. BPC-157 and the information on this page are intended strictly for in-vitro laboratory research and educational purposes. It is not an approved drug, dietary supplement, or food, and is not intended to diagnose, treat, cure, or prevent any disease or condition. It is not for human or veterinary use. Nothing here is medical advice or a claim of therapeutic benefit.